SSPL WEALTH PVT LTD

Saturday 21 Sep, 2024 06:20 AM

Adani Ports spurts on inking MoUs with Rorix Holdings TCS opens new delivery centre in Warsaw, Poland Patel Engg gains on emerging as L-1 bidder for Rs 240-cr project Poly Medicure Ltd leads losers in 'A' group Rossell India Ltd leads losers in 'B' group Torrent Pharma's Madhya Pradesh facility concludes GMP inspection with 1 observation CRISIL Ratings reaffirms 'A1+' rating of PNB Gilts Volumes soar at Asahi India Glass Ltd counter Consumer Durables shares fall Information Technology shares fall Aurobindo Pharma Ltd down for fifth straight session Tata Consultancy Services Ltd drops for fifth straight session Hindustan Copper Ltd spurts 1.3% Marico Ltd soars 1.41% Nestle India Ltd soars 2.1%, up for third straight session

Saravan Stocks

Hot Pursuit

Scrips, which has significant changes during the market hours.

Piramal Pharma rises after USA facility clears USFDA inspection

18-Apr-24 09:40 Hrs IST

Earlier in February 2024, the US Food and Drug Administration (USFDA) conducted a pre-approval inspection (PAI) inspection of the company?s Riverview (USA) facility from 29th January 2024 to 6th February 2024.

On conclusion of the inspection, a Form-483 was issued with 3 observations. The observations were classified under VAI (Voluntary Action Indicated).

Piramal Pharma is a pharmaceutical company that manufactures and develops a wide range of pharmaceutical solutions to reduce diseases. Piramal Pharma serves customers worldwide.

The pharmaceutical company reported a consolidated net profit of Rs 10.11 crore in Q3 FY24 as compared with net loss of Rs 90.18 crore recorded in Q3 FY23. Revenue from operations rose by 14.1% year-on-year to Rs 1,958.57 crore in Q3 FY24.

Powered by Capital Market - Live News

Attention Investors :

Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.

Attention Investors :

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.

Attention Investors :

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Attention Investors :

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

Email ID: info@ssplwealth.com Customers grievances : grievances@ssplwealth.com Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com, Mobile No: 7305522205

Hit Count : 35552535

Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified)